Antitumor drugs possessing topoisomerase I inhibition : applicable separation methods
スポンサーリンク
概要
- 論文の詳細を見る
- 2001-11-25
著者
-
OGUMA Toshihiro
Drug Metabolism & Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd.
-
Oguma T
Drug Metabolism And Physicochemical Property Research Laboratory Daiichi Pharmaceutical
関連論文
- Validation study of assay method for DE-310, a novel polymer-bound camptothecin derivative, and the free drug in mouse plasma by liquid chromatography with fluorimetric detection
- High-Performance Liquid Chromatographic Analysis of Lactone and Hydroxy Acid of New Antitumor Drug, DX-8951(Exatecan), in Mouse Plasma
- Analytical method of heparan sulfates using high-performance liquid chromatography turbo-ionspray ionization tandem mass spectrometry
- Antitumor drugs possessing topoisomerase I inhibition : applicable separation methods
- Validation study of a method for assaying DE-310, a macromolecular carrier conjugate containing an anti-tumor camptothecin derivative, and the free drug in human plasma by HPLC and LC/MS/MS